Roche sees diagnostic sales soar after acquisition:
This article was originally published in Clinica
Roche's diagnostic division had sales of SwFr4.6 billion ($3.3 billion) in 1998, reflecting the Swiss company's acquisition of Boehringer Mannheim in mid-1997. In the previous year, Roche's diagnostic sales were SwFr966 million. Roche says its PCR-based products and patient care division both had double-digit sales growth, its molecular biochemicals division had substantial growth, while its laboratory systems sales were "down sightly in a saturated market". Roche's total sales were SwFr24,660 million, up 31%. The figures do not include turnover for the orthopaedics company DePuy, in which Roche had a majority holding and which was sold to Johnson & Johnson in July 1998.
You may also be interested in...
The company will use the proceeds to fund clinical trials, expand commercialization of its targeted radiation therapy, and file for CE marking in Europe.
Advanced Medical Solutions said it will buy Raleigh Adhesive Coatings for £22m ($29m) in cash to strengthen its overall wound care business.
While Amgen said the Phase III GALACTIC-HF results for omecamtiv mecarbil did not meet its high expectations for the heart failure candidate, Cytokinetics sees a path to treating certain patients.